About
Photobiomodulation
Areas of Focus
Categories
Uncategorized Medical DeviceSeattle/Pacific Northwest
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
760
By Phase
PHASE2/PHASE3: 1NA: 4
By Status
COMPLETED: 3ACTIVE_NOT_RECRUITING: 2RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06229665Lead Sponsor
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)
PHASE2/PHASE3Active, not recruiting
75 participants
Started: Oct 25, 2023 · Completed: Jun 1, 2025
NCT06351605Lead Sponsor
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (EUROLIGHT) (EUROLIGHT)
N/ARecruiting
500 participants
Started: Sep 1, 2023 · Completed: Dec 31, 2026
NCT04522999Lead Sponsor
Study of Photobiomodulation Effect on Electroretinogram Outcomes in Dry Age-Related Macular Degeneration
NACompleted
15 participants
Started: Aug 20, 2020 · Completed: Aug 13, 2021
NCT04065490Lead Sponsor
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
NAActive, not recruiting
96 participants
Started: Sep 1, 2019 · Completed: Jun 1, 2022
NCT03878420Lead Sponsor
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE II)
NACompleted
44 participants
Started: Feb 14, 2019 · Completed: Jan 22, 2021
Locations (1)
Headquarters
Pulsbo, WA, United States
Map
Loading map...